CEO [CNOOC] CORRESP: (Original Filing)

[September 26, 2012 Mr. H. Roger Schwall Ms. Alexandra M. Ledbetter Mr. Norman von Holtzendorff Division of Corporation Finance 100 F Street, NE Mail Stop 7010 U.S.A. Re: CNOOC Limited Form 20-F for Fiscal Year Ended December 31, 2011 Filed April 20, 2012 Comment Letter Dated September 19, 2012 File No. 1-14966 Dear Mr. Schwall, Ms. Ledbetter and Mr. von]

By | 2016-03-11T02:08:53+00:00 September 26th, 2012|Categories: CEO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

AUO [AU OPTRONICS] 20-F/A: (Original Filing)

[Page EXPLANATORY NOTE i PART I 2 ITEM 5 OPERATING AND FINANCIAL REVIEW AND PROSPECTS 2 5.A. Operating Results 2 5.B. Liquidity and Capital Resources 14 5.C. Research and Development 18 5.D. Trend Information 19 5.E. Off-Balance Sheet Arrangements 19 5.F. 19 PART III 21 ITEM 18 FINANCIAL STATEMENTS 21 ITEM 19 21 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS 23 i] [Certification I, Shuang-Lang (Paul) Peng, certify that: 1. I have reviewed this annual report on Form 20-F/A of AU Optronics Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Andy Yang, certify that: 1. I have reviewed this annual report on Form 20-F/A of AU Optronics Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [906 Certification 100 F Street, N.E. Ladies and Gentlemen: Shuang-Lang (Paul) Peng, the President of AU Optronics Corp., certifies that, to the best of his knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained in the Report fairly presents, in all material respects, the financial condition] [906 Certification 100 F Street, N.E. Ladies and Gentlemen: Andy Yang, the Chief Financial Officer of AU Optronics Corp., certifies that, to the best of his knowledge: 1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and 2. the information contained in the Report fairly presents, in all material respects, the financial]

By | 2016-03-25T21:34:40+00:00 September 26th, 2012|Categories: AUO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

GAME [Shanda Games] 6-K: (Original Filing)

[Shanda Games Announces Adjustment of the Exercise Price of Share Options On September 14, 2012, the board of directors of Shanda Games Limited (“Shanda Games” or the “Company”) (Nasdaq: GAME), a leading online game developer, operator and publisher in China approved to adjust the exercise price for the share options held by the officers and employees of the Company and] [FORM 6-K Shanda Games Limited ——————————————————————————————————— No. 1 Office Building ——————————————————————————————————— x x n/a Shanda Games Limited Zhang Xiangdong Chief Executive Officer Description 99.1 Shanda Games Announces Adjustment of the Exercise Price of Share Options 6-K 1 htm_7049.htm LIVE FILING]

By | 2016-03-16T02:34:28+00:00 September 26th, 2012|Categories: Chinese Stocks, GAME, SEC Original|Tags: , , , , , |0 Comments

AUO [AU OPTRONICS] CORRESP: (Original Filing)

[September 26, 2012 Via EDGAR Division of Corporation Finance 100 F Street, NE Attn: Mr. Martin James Senior Assistant Chief Accountant Re: AU Optronics Corp. Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 27, 2012 File No. 001-31335 Dear Mr. James: For your convenience, we have included herein each of the Staff’s comments in italics, and]

By | 2016-03-25T21:36:35+00:00 September 26th, 2012|Categories: AUO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] 6-K: (Original Filing)

[China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 26, 2012 Shenzhen, China, September 26, 2012 About China Nepstar Chain Drugstore Ltd. http://www.nepstar.cn China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China’s largest retail drugstore chain based on the number of directly operated stores. As of June 30, 2012, the Company had 2,257 stores across 76 cities,]

By | 2016-03-07T04:21:31+00:00 September 26th, 2012|Categories: Chinese Stocks, NPD, SEC Original|Tags: , , , , , |0 Comments

LAS [Lentuo International] 6-K: (Original Filing)

[Lentuo International Announces Second Quarter 2012 Financial Results BEIJING, China, September 25, 2012/PRNewswire-FirstCall/ — Lentuo International Inc. (NYSE: LAS) (“Lentuo” or the “Company”), a leading non-state-owned automobile retailer headquartered in Beijing, today reported its financial results for the second quarter ended June 30, 2012. Second Quarter 2012 Financial Highlights · Revenues increased 21.2% to RMB792.5 million ($124.7 million) in the] [FORM 6-K LENTUO INTERNATIONAL INC. Building D, 2nd Floor, 56 East 4th Ring South Road Chaoyang District, Beijing 100023 People’s Republic of China (86-10) 6778 3955 (Address of Principal Executive Offices) Form 20-F x Form 40-F o Yes o No x Yes o No x Yes o No x S Number Description of Document]

By | 2016-03-29T17:03:36+00:00 September 26th, 2012|Categories: Chinese Stocks, LAS, SEC Original|Tags: , , , , , |0 Comments

DHRM [Dehaier Medical Systems] 8-K: (Original Filing)

[Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer DHRM BEIJING, Sept. 21, 2012 /PRNewswire-FirstCall/ — Dehaier Medical Systems Ltd. (NASDAQ: During the three-year term of the agreement, the purchaser will procure Dehaier's proprietary air compressors, customized trolleys and accessories, which will be used in hospital intensive care units, emergency rooms, operation rooms, respiratory departments and] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): September 21, 2012 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Suite 501, Jiuzhou Plaza 83 Fuxing Road, Haidian District Beijing 100856 China +86 (10) 5166-0080 Not Applicable (Former name or former address, if changed since]

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President] [Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating] [Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 -- Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both] []

By | 2016-03-24T00:58:41+00:00 September 26th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar